IOVANCE BIOTHERAPEUTICS, INC.
For the period ended Mar 31, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 7, 2026
IOVA$8.17+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
EXHIBIT INDEX
| | ||
| Exhibit | | Description |
| 3.1 | | Certificate of Incorporation, as amended, of Registrant (incorporated herein by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed with the Commission on July 10, 2023). |
| 3.2 | | Fourth Amended and Restated Bylaws of Iovance Biotherapeutics, Inc. (incorporated herein by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K filed with the Commission on March 29, 2024). |
| 31.1++ | Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer. | |
| 31.2++ | Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer. | |
| 32.1++ | Section 1350 Certification of Chief Executive Officer (furnished herewith). | |
| 32.2++ | Section 1350 Certification of Principal Financial Officer (furnished herewith). | |
| 101.INS++ | | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
| 101.SCH++ | | Inline XBRL Taxonomy Schema Linkbase Document. |
| 101.CAL++ | | Inline XBRL Taxonomy Calculation Linkbase Document. |
| 101.DEF++ | | Inline XBRL Taxonomy Definition Linkbase Document. |
| 101.LAB++ | | Inline XBRL Taxonomy Labels Linkbase Document. |
| 101.PRE++ | | Inline XBRL Taxonomy Presentation Linkbase Document. |
| 104 | | Cover Page Interactive Data File (the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
| ++#* | Filed herewith (unless otherwise noted as being furnished herewith).Indicates a management contract or compensatory plan or arrangement.Certain portions of the Exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.